70 related articles for article (PubMed ID: 38528115)
21. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework.
Khan A; Fornes O; Stigliani A; Gheorghe M; Castro-Mondragon JA; van der Lee R; Bessy A; Chèneby J; Kulkarni SR; Tan G; Baranasic D; Arenillas DJ; Sandelin A; Vandepoele K; Lenhard B; Ballester B; Wasserman WW; Parcy F; Mathelier A
Nucleic Acids Res; 2018 Jan; 46(D1):D260-D266. PubMed ID: 29140473
[TBL] [Abstract][Full Text] [Related]
22. Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells.
Tam KJ; Hui DHF; Lee WW; Dong M; Tombe T; Jiao IZF; Khosravi S; Takeuchi A; Peacock JW; Ivanova L; Moskalev I; Gleave ME; Buttyan R; Cox ME; Ong CJ
Sci Rep; 2017 Sep; 7(1):11501. PubMed ID: 28904399
[TBL] [Abstract][Full Text] [Related]
23. Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.
Beltran H; Wyatt AW; Chedgy EC; Donoghue A; Annala M; Warner EW; Beja K; Sigouros M; Mo F; Fazli L; Collins CC; Eastham J; Morris M; Taplin ME; Sboner A; Halabi S; Gleave ME
Clin Cancer Res; 2017 Nov; 23(22):6802-6811. PubMed ID: 28842510
[No Abstract] [Full Text] [Related]
24. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
[TBL] [Abstract][Full Text] [Related]
26. Expression of Semaphorin 3C in Breast Cancer and its Impact on Adhesion and Invasion of Breast Cancer Cells.
Malik MF; Satherley LK; Davies EL; Ye L; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1281-6. PubMed ID: 26977026
[TBL] [Abstract][Full Text] [Related]
27. The Molecular Taxonomy of Primary Prostate Cancer.
Cancer Genome Atlas Research Network
Cell; 2015 Nov; 163(4):1011-25. PubMed ID: 26544944
[TBL] [Abstract][Full Text] [Related]
28. Integrative clinical genomics of advanced prostate cancer.
Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
[TBL] [Abstract][Full Text] [Related]
29. RSAT 2015: Regulatory Sequence Analysis Tools.
Medina-Rivera A; Defrance M; Sand O; Herrmann C; Castro-Mondragon JA; Delerce J; Jaeger S; Blanchet C; Vincens P; Caron C; Staines DM; Contreras-Moreira B; Artufel M; Charbonnier-Khamvongsa L; Hernandez C; Thieffry D; Thomas-Chollier M; van Helden J
Nucleic Acids Res; 2015 Jul; 43(W1):W50-6. PubMed ID: 25904632
[TBL] [Abstract][Full Text] [Related]
30. Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation.
Man J; Shoemake J; Zhou W; Fang X; Wu Q; Rizzo A; Prayson R; Bao S; Rich JN; Yu JS
Cell Rep; 2014 Dec; 9(5):1812-1826. PubMed ID: 25464848
[TBL] [Abstract][Full Text] [Related]
31. Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury.
Huang ZM; Gao E; Fonseca FV; Hayashi H; Shang X; Hoffman NE; Chuprun JK; Tian X; Tilley DG; Madesh M; Lefer DJ; Stamler JS; Koch WJ
Sci Signal; 2013 Oct; 6(299):ra95. PubMed ID: 24170934
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Gao J; Aksoy BA; Dogrusoz U; Dresdner G; Gross B; Sumer SO; Sun Y; Jacobsen A; Sinha R; Larsson E; Cerami E; Sander C; Schultz N
Sci Signal; 2013 Apr; 6(269):pl1. PubMed ID: 23550210
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
[TBL] [Abstract][Full Text] [Related]
34. NCBI GEO: archive for functional genomics data sets--update.
Barrett T; Wilhite SE; Ledoux P; Evangelista C; Kim IF; Tomashevsky M; Marshall KA; Phillippy KH; Sherman PM; Holko M; Yefanov A; Lee H; Zhang N; Robertson CL; Serova N; Davis S; Soboleva A
Nucleic Acids Res; 2013 Jan; 41(Database issue):D991-5. PubMed ID: 23193258
[TBL] [Abstract][Full Text] [Related]
35. Semaphorin 3C is involved in the progression of gastric cancer.
Miyato H; Tsuno NH; Kitayama J
Cancer Sci; 2012 Nov; 103(11):1961-6. PubMed ID: 22924992
[TBL] [Abstract][Full Text] [Related]
36. The mutational landscape of lethal castration-resistant prostate cancer.
Grasso CS; Wu YM; Robinson DR; Cao X; Dhanasekaran SM; Khan AP; Quist MJ; Jing X; Lonigro RJ; Brenner JC; Asangani IA; Ateeq B; Chun SY; Siddiqui J; Sam L; Anstett M; Mehra R; Prensner JR; Palanisamy N; Ryslik GA; Vandin F; Raphael BJ; Kunju LP; Rhodes DR; Pienta KJ; Chinnaiyan AM; Tomlins SA
Nature; 2012 Jul; 487(7406):239-43. PubMed ID: 22722839
[TBL] [Abstract][Full Text] [Related]
37. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Cerami E; Gao J; Dogrusoz U; Gross BE; Sumer SO; Aksoy BA; Jacobsen A; Byrne CJ; Heuer ML; Larsson E; Antipin Y; Reva B; Goldberg AP; Sander C; Schultz N
Cancer Discov; 2012 May; 2(5):401-4. PubMed ID: 22588877
[TBL] [Abstract][Full Text] [Related]
38. FOXA1: a transcription factor with parallel functions in development and cancer.
Bernardo GM; Keri RA
Biosci Rep; 2012 Apr; 32(2):113-30. PubMed ID: 22115363
[TBL] [Abstract][Full Text] [Related]
39. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
[TBL] [Abstract][Full Text] [Related]
40. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.
Wang D; Garcia-Bassets I; Benner C; Li W; Su X; Zhou Y; Qiu J; Liu W; Kaikkonen MU; Ohgi KA; Glass CK; Rosenfeld MG; Fu XD
Nature; 2011 May; 474(7351):390-4. PubMed ID: 21572438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
